Doctors detect tumors in the bloodstream three years before diagnosis. In a new study published in the journal Cancer ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the National Comprehensive Cancer Network (NCCN) has included the Shield blood test in its updated ...

A new "liquid biopsy" test can help fast-track lung cancer patients to receive targeted therapy up to two weeks earlier, ...

Guardant Health (GH) announced that the National Comprehensive Cancer Network, NCCN, has included the Shield blood test in its updated colorectal ...

World Environment Day is observed globally on June 5, with this year's theme, "Beat Plastic Pollution," drawing attention to ...

Explore the potential benefits of omega-3s, curcumin, vitamin D, and probiotics for rheumatoid arthritis symptom management.

A Breakthrough Botanical Formula Backed by 2025 Nobel Research Offers Lasting Relief from Ear Ringing and Auditory Imbalance ...

Don’t miss your chance to try Totally Derma - the premium joint and skin-boosting collagen supplement that experts love to ...

When trying to remove life-threatening clots from blood vessels, current technologies are successful on only about half of ...

Detection of cancer before a clinical diagnosis could give patients and caregivers more time for intervention and may lead to ...

Genetic material shed by tumors can be detected in the bloodstream three years prior to cancer diagnosis, according to a study led by investigators at the Ludwig Center at Johns Hopkins, Johns Hopkins ...